Related content

Human papillomavirus vaccines

By Breitburd F.   Coursaget P.  

Seminars in Cancer Biology, Vol. 9, Iss. 6, 1999-12 ,pp. : 431-444

Academic Press

Access to resources Recommend Favorite

Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study

By Wu En-Qi   Liu Bin   Cui Jian-Feng   Chen Wen   Wang Jian-Bing   Lu Liang   Niyazi Mayineur   Zhao Chao   Ren Sheng-Da   Li Chang-Qing   Gong Xiang-Zhen   Smith Jennifer   Belinson Jerome   Liaw Kai-Li   Velicer Christine   Qiao You-Lin  

Cancer Causes and Control, Vol. 24, Iss. 4, 2013-04 ,pp. : 795-803

Springer Publishing Company

Access to resources Recommend Favorite

A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas

By Koyamatsu Y.   Yokoyama M.   Nakao Y.   Fukuda K.   Saito T.   Matsukuma K.   Iwasaka T.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 547-551

Elsevier

Access to resources Recommend Favorite

Cervical Cancer: The Potential Role of Human Papillomavirus (HPV)-Specific Vaccines in Prevention and Treatment

By Schneider A.  

American Journal of Cancer, Vol. 2, Iss. 4, 2003-01 ,pp. : 253-268

Adis International

Access to resources Recommend Favorite

Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer

By Berkhof Johannes   Bogaards Johannes A  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1817-1821

Future Medicine

Access to resources Recommend Favorite